Found 298 articles for: "alopecia"
Melatonin and the Human Hair Follicle
March 2023 | Volume 22 | Issue 3 | Original Article | 260 | Copyright © March 2023
Background: Melatonin, a pleiotropic hormone, affects the physiological processes including that of the hair follicle. We seek to identify the scientific evidence to support the poten...
Read MoreUtilization Management Barriers Among Patients With Cicatricial Alopecia
March 2023 | Volume 22 | Issue 3 | Features | 312 | Copyright © March 2023
Citation: Rypka K, Pathoulas J, Wharton K, et al. Utilization management barriers among patients with cicatricial alopecia. J Drugs Dermatol. 2023;22(3):312-314. doi:10.36849/JDD.684...
Read MoreDermTok: How TikTok Is Changing the Landscape of Dermatology Patient Education
March 2023 | Volume 22 | Issue 3 | Features | 302 | Copyright © March 2023
Background: TikTok gives its users a platform to share and view short videos on a wide range of topics, including dermatology related topics. This project sought to analyze the source...
Read MoreTopical Minoxidil Adherence in Patients With Alopecia
March 2023 | Volume 22 | Issue 3 | Original Article | 252 | Copyright © March 2023
Background: Non-adherence to topical minoxidil in alopecia patients is a barrier to efficacy. Understanding patient factors associated with adherence and non-adherence may provide act...
Read MoreGraham-Little-Piccardi-Lasseur Syndrome: A Case Report
February 2023 | Volume 22 | Issue 2 | Case Reports | 210 | Copyright © February 2023
Graham-Little Piccardi-Lasseur syndrome is a rare dermatosis that affects the hair follicles throughout the body and often presents with a progressive cicatricial alopecia of the scalp that is unrespo...
Read MoreSupplement Individual Article: NECOM Skincare Algorithm for Patients With Cancer and Survivors
January 2023 | Volume 22 | Issue 1 | Supplement Individual Articles | 3595573 | Copyright © January 2023
Background: Cancer treatment-related cutaneous adverse events (cAEs) frequently occur, which can interfere with anticancer treatment outcomes and can severely impact quality of life f...
Read MoreA Review of the Challenges and Nuances in Treating Rosacea in Asian Skin Types Using Cleansers and Moisturizers as Adjuncts
January 2023 | Volume 22 | Issue 1 | Original Article | 45 | Copyright © January 2023
Background: Rosacea is primarily an inflammatory disease of facial skin associated with impaired skin barrier function. While it is commonly thought of as a Caucasian person's disease...
Read MoreTretinoin Review With Newer Formulations: Providing Effective and Tolerable Solutions in Clinical Practice
January 2023 | Volume 22 | Issue 1 | Original Article | 35 | Copyright © January 2023
Topical tretinoin has historically been limited by poor tolerability and molecular instability. Research advances have enhanced its efficacy and tolerability, along with reducing oxidation and photode...
Read MoreExamining the Potential for Koebnerization and Disease Precipitation in Cicatricial Alopecias
January 2023 | Volume 22 | Issue 1 | Original Article | 29 | Copyright © January 2023
The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following pro...
Read MoreAcute Onset Linear Lichen Planus Pigmentosus of the Forehead: A Case Series
January 2023 | Volume 22 | Issue 1 | Case Reports | 94 | Copyright © January 2023
Linear lichen planus pigmentosus (LPP) of the face is a rare variant of lichen planus, with only a few cases published in the literature.1 It is an inflammatory condition with unknown et...
Read MoreAn Analysis of Alopecia Related Content on Instagram and TikTok
December 2022 | Volume 21 | Issue 12 | Original Article | 1316 | Copyright © December 2022
Background: Social media platforms continue to grow in popularity and have become common sources of medical information and education for patients struggling with hair loss.
Read More Syringotropic Mycosis Fungoides: A Variant of Folliculotropic or a Distinct Subtype of Adnexotropic Mycosis Fungoides?
December 2022 | Volume 21 | Issue 12 | Case Reports | 1362 | Copyright © December 2022
Mycosis fungoides (MF) is a slowly progressive form of cutaneous T-cell lymphomas (CTCL). MF is classified into 4 subtypes including folliculotropic MF (FMF). Infiltration of both hair follicles and e...
Read MoreOff-Label Uses of JAK Inhibitors in Dermatology
October 2022 | Volume 21 | Issue 10 | Features | 1143 | Copyright © October 2022
The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is a crucial component of immune function, and JAK inhibitors allow dermatologists to regulate this pathway in ce...
Read MoreJAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies
December 2022 | Volume 21 | Issue 12 | Original Article | 1298 | Copyright © December 2022
Dermatologists treating atopic dermatitis are interested in the safety profile of the recently available JAK inhibitors, upadacitinib and abrocitinib, especially after they received boxed safety warni...
Read MoreRefractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
December 2022 | Volume 21 | Issue 12 | Case Reports | 1366 | Copyright © December 2022
Background: In the last several years, oral tofacitinib has become an increasingly utilized off-label treatment option for immune-mediated skin conditions such as alopecia areata (AA)...
Read MoreA Potential Alternative Treatment for Vitiligo: An Observational Study on Tacrolimus 0.3% Lotion
December 2022 | Volume 21 | Issue 12 | Features | 1370 | Copyright © December 2022
Vitiligo is a complex multifactorial disorder of depigmentation affecting 0.5 to 2% of the world's population without specific gender or racial prevalence.1 Though no treatments are FDA app...
Read MoreA Case of Successful Management of Adult-Onset Linear IgA Bullous Disease With Sulfasalazine During the COVID-19 Pandemic
December 2022 | Volume 21 | Issue 12 | Case Reports | 1355 | Copyright © December 2022
Linear IgA bullous disease (LABD) is a rare, acquired, autoimmune, pruritic, and blistering skin condition. Dapsone is a first line treatment option, however, there are limited options if this fails, ...
Read MoreEvaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia
November 2022 | Volume 21 | Issue 11 | Original Article | 1166 | Copyright © November 2022
Androgenetic alopecia (AGA) in men and women is the most common cause of hair loss. Affected individuals may experience psychological distress and social withdrawal. Current treatment options for AGA,...
Read MoreComparison of Pediatric Dermatology Conditions Across Telehealth and In-Person Visits During the COVID-19 Pandemic
November 2022 | Volume 21 | Issue 11 | Features | 1260 | Copyright © November 2022
Understanding the utility of virtual visits in pediatric dermatology practice has become increasingly important in the telehealth era. We compared the conditions diagnosed in pediatric dermatology bet...
Read MoreThe Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1070 | Copyright © October 2022
Background: Approximately 30% to 40% of alopecia areata (AA) patients have atopic dermatitis. Studies suggest that antihistamines and dupilumab may be effective treatments; however, t...
Read More